|
|
||||||||
-cardiac myosin heavy chain gene mutation impairs
contraction and relaxation function of cardiac myocytes
1 Cardiovascular and Pulmonary
Research Institute, Allegheny University of the Health Sciences,
Pittsburgh, Pennsylvania 15212;
3 Department of Genetics, Left Ventricular (LV) myocytes were isolated
from 15-wk-old male mice bearing the
Arg403
transgenic mice; calcium
ALTHOUGH MOST CARDIAC HYPERTROPHY occurs as a secondary
response to hemodynamic overload or other mechanical factors,
hypertrophy can also be induced by inherited mutations (28). A number
of different missense mutations in the head and head/rod region of the
To further understand the physiological and pathological mechanisms by
which the Arg403 To address this question, we have studied the structure and function of
isolated cardiac myocytes bearing the
Arg403 Heterozygous Preparation of mouse ventricular myocytes.
Cardiac myocytes were prepared from 15-wk-old male wild-type
(n = 17) and
Measurement of contractile performance.
Myocytes were transferred to a warmed (37°C) and continuously
perfused cell chamber located on the stage of an inverted microscope (Nikon). The chamber was perfused with physiological buffer containing (in mM) 120 NaCl, 2.6 KCl, 1.2 MgCl2, 1.2 KH2PO4,
11 glucose, 5 HEPES, 25 NaHCO3, 2 taurine, 1 pyruvate, and 1 Ca2+.
Myocyte contraction was induced once per second (1 Hz) by platinum field electrodes placed in the cell chamber that were attached to a
stimulator (Grass S48, Grass Instruments). Cell images were continuously acquired through a ×40 objective lens (Nikon) and transmitted to a 240 sample/s charge-coupled device (CCD) video camera
(TM-640, Pulnix). The output from the CCD camera was displayed on a
video monitor (PVM-135, Sony). Myocytes were selected for study
according to the following criteria (6): a rod-shaped appearance with
clear striations and no membrane blebs, no spontaneous contractions
when unstimulated in 1 mM Ca2+,
and steady diastolic length and contractile amplitude at basal stimulation rates. Myocyte length was measured using a video motion edge detector (VED103, Crescent Electronics), and the data were acquired at 240 samples/s, stored, and analyzed on a Dell 433 computer.
Myocyte dimensions were calibrated with a hemacytometer grid placed on
the microscope stage.
Measurement of myocyte transient
Ca2+
concentration.
LV myocytes from 9 Morphological evaluation.
Light microscopic observation of isolated myocytes was done to evaluate
differences in cell morphology. Freshly isolated myocytes from both
RNA extraction and Northern blot analysis.
Total RNA was isolated from the left ventricles of WT and
Data analysis.
LV myocytes from four
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
Gln
-cardiac
myosin heavy chain missense mutation
(
-MHC403/+), a model of
familial hypertrophic cardiomyopathy. LV myocytes were classified
morphologically: type I, rod shaped with parallel myofibrils; type II,
irregularly shaped, shorter and wider than wild-type (WT) control
cells, with parallel myofibrils; and type III, irregularly
shaped with disoriented myofibrils. Compared with WT myocytes,
-MHC403/+ myocytes had fewer
type I cells (WT = 74 ± 3%,
-MHC403/+ = 41 ± 4%,
P < 0.01) and more type III cells
(WT= 12 ± 3%,
-MHC403/+ = 49 ± 7%, P < 0.01). In situ
histology also demonstrated marked myofibrillar disarray in the
-MHC403/+ hearts. With the use
of video edge detection, myocytes were paced at 1 Hz (37°C) to
determine the effects of the mutation on myocyte function.
End-diastolic length was reduced in mutant myocytes, but fractional
shortening (% contraction) and sarcomere length were not.
Velocity of contraction
(
dL/dtmax)
was depressed in mutant cells, but more in type II and III cells
(
31%) than in type I cells (
18%). Velocity of
relaxation
(+dL/dt)
was also depressed more in type II and III cells (
38%) than in
type I cells (
16%). Using fura 2 dye with intracellular
Ca2+ transients, we demonstrated
that in
-MHC403/+ myocytes, the
amplitude of the Ca2+ signal
during contraction was unchanged but that the time required for decay
of the signal to decrease 70% from its maximum was delayed significantly (WT = 159 ± 8 ms;
-MHC403/+ = 217 ± 14 ms,
P < 0.01). Sarco(endo)plasmic
reticulum Ca2+-ATPase mRNA levels
in
-MHC403/+ and WT mice were
similar. These data indicate that the altered cardiac dysfunction of
-MHC403/+ myocytes is directly
due to defective myocyte function rather than to secondary changes in
global cardiac function and/or loading conditions.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
-cardiac myosin heavy chain (MHC) gene can cause familial hypertrophic cardiomyopathy (FHC) (7, 8, 10, 24). One of these
mutations, Arg403
Gln has
nearly 100% penetrance and dramatically reduces the life expectancy of
affected individuals (8). However, the mechanism by which the
Arg403
Gln mutation and
other mutations in sarcomere protein genes cause cardiac hypertrophy
and sudden death is not certain.
Gln
missense mutation causes FHC, a murine model was created by introducing
this missense mutation into the
-cardiac MHC gene (9). Heterozygous
mice bearing the Arg403
Gln missense mutation (designated
-MHC403/+) exhibit
alterations in cardiac function and histopathology characteristic of
human FHC, homologous to human
-cardiac MHC, with 92% identity overall (9). The
-MHC403/+
mouse hearts exhibit lower cardiac output and abnormal left ventricular (LV) relaxation, and they also demonstrate fibrosis. Whether the alteration in cardiac function of mutant hearts is directly due to
defective myocyte function or whether these differences in function are
secondary to changes in cardiac structure and/or loading conditions
remains uncertain.
Gln mutation from
left ventricles of
-MHC403/+
mice. We examined the morphology of the myocytes and observed that many
of the mutant myocytes were shorter and wider than wild-type (WT)
myocytes, with irregular cellular borders and myofibrillar disarray. We
measured contractile and relaxation properties by means of
computer-assisted video motion edge detection. Measuring these indexes
from single cardiac myocytes provides intrinsic contractile and
relaxation function, independent of the extracellular matrix and
systemic hemodynamic and neurohormonal effects. After we determined
that myocyte relaxation was delayed and accompanied by delayed
recovery of Ca2+ transients, we
measured the message for sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) to see whether
it was altered in the mutant.
![]()
METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
-MHC403/+ mice
were bred by mating
-MHC403/+
mice as described previously (9). WT mice were the littermates of
-MHC403/+ mice.
-MHC403/+ mice
(n = 19). In brief, the heart was
rapidly excised and submerged in
Ca2+-free Tyrode solution
containing (in mM) 140 NaCl, 5.4 KCl, 1 MgCl2, 0.33 NaH2PO4,
10 glucose, and 5 HEPES at pH 7.4. The aorta was cannulated with a
blunt-tip needle (20 gauge) on a perfusion apparatus. The heart was
perfused for 3 min with Tyrode solution and was then perfused with
Tyrode solution with 2% calf serum (Sigma) and 75 U/ml each of
collagenase types 1 and 2 (Worthington). Perfusion pressure was
monitored continuously through an in-line pressure transducer during
digestion. Perfused LV free walls were excised when perfusion pressure
reached ~20-30 mmHg from an initial pressure of 60-70 mmHg,
which provided a consistent quality of myocytes (>50% yield).
Perfusion was identical for both groups. The digested tissue was then
placed in the separate petri dish filled with Tyrode solution with 2%
calf serum and 10% bovine albumin (fraction V, Sigma). All perfused
media were maintained at 37°C, and all solutions were continuously
bubbled with 95% O2-5%
CO2. After the tissue was minced
and gently aspirated, the cells were teased apart to disperse myocytes,
and the myocyte-containing solution was placed in a tube to allow
viable myocytes to settle by gravity. Myocytes were stored at room
temperature before use, and the protocol was completed within 3 h after
isolation to avoid any deterioration due to prolonged storage of cells.
-MHC403/+
and 10 WT mice were loaded with 3.8 mM of fura 2-AM (Sigma) dissolved
in dimethyl sulfoxide at room temperature (20°C) for 30 min in
Tyrode solution with 2% calf serum and 10% bovine albumin (fraction
V, Sigma). After cells were loaded, they were washed with Tyrode
solution for 30 min and placed in the myocyte perfusion chamber on the
microscope, as described in Measurement of contractile
performance. The myocytes were excited by
ultraviolet light (wavelengths 340 and 380 nm, alternately) and the
fura emission wavelength (510 nm) was synchronously monitored by the
Photoscan dual-beam spectrofluorophotometer (Photon Technology).
Intracellular free Ca2+ was
measured as the fluorescence ratio (340/380) because high mitochondrial
fluorescence affects calculated
Ca2+ concentration in fura
2-loaded myocytes, and the measurement averages the fluorescent signal
from an area within a single cell (29). Loaded myocytes were stimulated
as described above. Measurements from an individual myocyte were taken
after a steady state for myocyte contraction was reached following
stimulation at 1 Hz. The protocol was completed within 3 h after
isolation to avoid any deterioration due to prolonged storage of cells.
-MHC403/+ and WT mice were
fixed in 4% paraformaldehyde. An aliquot of cells was washed in PBS
with 0.5% Tween 20 and incubated with 10 µg/ml of
rhodamine-conjugated phalloidin (Sigma) for 30 min at room
temperature. After the cells were stained and washed in PBS, they were
mounted and observed with a Leica confocal laser-scanning microscope.
Both differential interference contrast and fluorescent images were
collected and analyzed using PhotoImage. In addition, two
-MHC403/+ and two WT mouse
hearts were fixed with 2% phosphate-buffered paraformaldehyde. The LV
myocardial samples were embedded in aldehyde epoxy resin. Sections were
cut to a 1-µm thickness and stained with toluidine blue. Light
microscopic evaluation was used to determine in situ myocyte morphology
independent of the perfusion pressure used in isolated myocytes.
-MHC403/+ mice using Trizol
(GIBCO BRL) according to the manufacturer's protocol. Total RNA (20 µg) was separated on an agarose-formaldehyde gel and subsequently
blotted to a nylon hybridization transfer membrane (GeneScreen
Plus, NEN Life Science Products). The oligonucleotides used as
transcript-specific probes were as follows: SERCA
5'-AACAACGCACATGCACGCACCCGAACACCCTTATATTTCTGCAAATGG and
5'-GGAACATGTAGACCATGTAGTTGAGGTCAATGAAG. The hybridization signal for SERCA was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) signal intensity.
-MHC403/+
(n = 1,020) and four WT mice
(n = 860) were classified
morphologically using light microscopy: type I, rod shaped with
parallel myofibrils; type II, irregularly shaped, shorter and wider
than other types, with parallel myofibrils; and type III, irregularly
shaped with disoriented myofibrils. The percentage of myocytes from
each type was calculated from each animal, and these data were used for
the mean values.
dL/dt),
and rate of lengthening
(+dL/dt).
The smoothing combination was chosen to have minimal effect on the
data, the median filtering rid the waveform of any noise spikes, and
the linear filtering approximated the transitions between samples of
the length of signal. This results in a slight underestimation of the
true
dL/dt values but has little effect on the relaxation calculations.
Therefore, a minimum of three stable beats was analyzed to
avoid underestimation during the peak contraction. The
contraction slope was calculated from 10 to 90% of full
contraction. The time from peak relaxation (+dL/dtmax)
to 50% resting length (TR 50%) was also calculated. The time
from peak relaxation to 70% resting length (TR 70%) was also
calculated, because the length curves during relaxation were biexponential, with a rapid early decay followed by a slower decay.
-MHC403/+ cells,
additional statistical analysis was performed on cells that were
both longer and shorter compared with wild-type control cells.
| |
RESULTS |
|---|
|
|
|---|
LV myocytes from both
-MHC403/+
and wild-type mice were classified morphologically. Compared with WT
myocytes,
-MHC403+ myocytes
showed more irregular cell outlines with apparently more cell
junctional areas and less well-aligned myofibrils within the cells but
with no change in sarcomere length, which ranged between 1.81 and 1.87 mm (Figs. 1 and 2). Compared with WT
hearts,
-MHC403/+ hearts had
fewer type I cells (WT = 74 ± 3%;
-MHC403/+ = 41 ± 4%,
P < 0.01) and more type III cells
(WT = 12 ± 3%;
-MHC403/+ = 49 ± 7%, P < 0.01). The altered
morphology was observed in myocytes isolated in both
Ca2+-containing (Fig. 1) and
Ca2+-free (Fig.
2) solutions. Both myocytes and tissue
sections (Fig. 1, C and
D) from
-MHC403/+ mice showed irregular
morphology, i.e., shorter in length and wider than WT, with misaligned
myofibrils. Staining with rhodamine-phalloidin for actin filaments
and examination by confocal microscopy revealed disorganization of the
myofibrils in type III cells (Fig. 2).
|
|
Indexes of contractile and relaxation function are summarized in Table
1. In
-MHC403/+ LV myocytes,
diastolic and systolic lengths were significantly less than in WT
myocytes (WT = 130 ± 3,
-MHC403/+ = 118 ± 3 µm, P < 0.05), but percent
contraction was similar (Fig. 3). Both
contractile and relaxation properties of
-MHC403/+ mice were
significantly impaired (P < 0.05) compared with
those of WT mice. For example, the rate of contraction
(
dL/dtmax), contraction slope, and relaxation times (TR 50% and TR 70%) were altered by 20-25% in the
-MHC403/+ myocytes compared
with WT myocytes (Table 1 and Fig. 4).
|
|
|
Because there were more type III cells, which were shorter and wider
with disoriented myofibrils, in the
-MHC403/+, it was important to
determine whether this alone could account for the differences in
contractile function. Accordingly, we divided the data from the mutant
myocytes into those myocytes with less than the mean end-diastolic
length (<120 µm) and those with an end-diastolic length >120
µm. The longer cells were predominantly type I, rod-shaped myocytes
with parallel myofibrils. Whereas both subgroups of myocytes
demonstrated impaired contractile and relaxation function (Table
2), the impairment was greater in shorter
cells.
|
Changes in
Ca2+
concentration during relaxation and contraction.
To begin to understand why
-MHC403/+-derived LV myocytes
had impaired function, Ca2+
concentrations were recorded during the contraction-relaxation cycle of
isolated myocytes. The changes in intracellular
Ca2+ concentration associated with
contraction were estimated by comparing the emission spectra of fura 2 after excitation of loaded myocytes at 340 and 380 nm. The levels of
diastolic free Ca2+ concentration
and Ca2+ signal during
contraction, monitored as the 340/380 ratio, was similar in WT and
-MHC403/+ myocytes (Table
3). However, the times required for decay
of this signal by 50 and 70% resting lengths (TRC 50% and TRC 70%, respectively) were significantly prolonged
(P < 0.001), suggesting an impaired
ability to sequester Ca2+ into the
sarcoplasmic reticulum during relaxation (Table 3 and Fig.
5).
|
|
Northern blot analysis of SERCA.
Expression of SERCA mRNA from WT and
-MHC403/+ mice was similar,
i.e., no changes in the 28S and 18S bands were observed (Fig. 6). The normalization to GAPDH also
demonstrated no differences (WT = 2.01 ± 0.18,
-MHC403/+ = 2.13 ± 0.13).
|
| |
DISCUSSION |
|---|
|
|
|---|
Understanding the effects of the
Arg403
Gln missense
mutation on myocyte contraction and relaxation is central to
understanding how mutations in the cardiac MHC gene cause FHC. In the
present study, we demonstrated that many of the myocytes from
heterozygous
-MHC403/+ mice,
which bear the FHC-causing mutation
Arg403
Gln, are
morphologically altered, i.e., shorter and wider with marked
misalignment of myofibrils, compared with myocytes from WT mice.
In an earlier study by Maron et al. (23) in 52 patients with
hypertrophic cardiomyopathy, cellular disorganization was widely distributed throughout the left ventricle as a hallmark of hypertrophic cardiomyopathy. Recently, Geisterfer-Lowrance et al. (9) generated a
mouse model simulation of FHC by introducing an
Arg403
Gln mutation into
the
-cardiac MHC gene, which is highly homologous to human
-cardiac MHC with 92% identity overall. They (9) demonstrated that
cardiac dysfunction, i.e., lower cardiac output and abnormal LV
relaxation, preceded histopathological changes such as ventricular
hypertrophy with fibrosis, indicating that altered mechanical
properties caused abnormal cardiac function. In the present study,
isolation of single cardiac myocytes, which provides intrinsic myocyte
function independent of systemic hemodynamic and neurohormonal effects,
revealed that both contraction and relaxation properties of
-MHC403/+ myocytes were
significantly impaired. Marian et al. (22) recently demonstrated that
human myocytes expressing mutant cardiac troponin T
(Arg92
Gln), known to
cause hypertrophic cardiomyopathy in humans, demonstrated impaired contractility.
Interestingly, we noted that many LV
-MHC403/+ myocytes were shorter
and wider, with marked misalignment of myofibrils, compared with WT
myocytes. However, sarcomere lengths were not altered. Not all
myopathic myocytes demonstrate these abnormalities, e.g., the myocytes
from cardiomyopathic Syrian hamsters are actually longer and wider (14,
15). One possible difference between their results and ours could be
due to the amount of Ca2+ in
solution. Therefore, to determine whether
Ca2+ in the isolation solution was
responsible for the alteration of cell morphology, the myocytes in the
present study were also isolated in
Ca2+-free solution, as shown in
Fig. 2. Under these conditions, we confirmed that
-MHC403/+ myocytes, which were
isolated without Ca2+ in the
solution, were also shorter and wider. Another consideration is that
the isolation procedures caused the disarray in myocyte architecture.
However, isolation procedures were identical for both groups.
Furthermore, we also observed disorientation of myofibrils in situ in
perfusion-fixed myocardium without myocyte isolation (Fig. 1).
Accordingly, the presence or absence of
Ca2+ in the isolation solution or
the effects of enzymatic myocyte isolation was not responsible for the
altered morphology. Another important morphological aspect of the LV
-MHC403/+ myocytes is an
irregular cell outline with apparently more cell junctional areas (Fig.
1). More importantly, we also noted that many
-MHC403/+ myocytes showed less
well-aligned myofibrils within the cells, which may be responsible for
the primary functional defects.
Because the population of shorter and wider cells was increased in
-MHC403/+, it was important to
determine whether this alone was responsible for the depressed
contractile
(
dL/dt)
and relaxation function (+dL/dt;
TR 50% and TR 70%). When myocytes of similar length, generally
characterized by aligned myofibrils, were compared (Table 2), it was
found that the
-MHC403/+
myocytes also demonstrated impaired contraction and relaxation function, albeit less so than the shorter myocytes. Thus the shorter and wider myocytes with greater misalignment of myofibrils demonstrated more severe expression of the myopathy. We then wanted to determine whether the difference in end-diastolic length resulted in differences in the extent of shortening. When these two variables were correlated, it was found that end-diastolic length correlated significantly with
the extent of shortening of myocytes, but there was no correlation with
percent contraction of the myocytes (Fig.
7). This indicates that the extent of
shortening was preserved regardless of myocyte length in
-MHC403/+ mice. However, the
rates of contraction and relengthening as well as the times for 50 and
70% recovery were depressed in LV myocytes from
-MHC403/+ mice.
|
In addition to distinct abnormalities of morphology and mechanical
function of
-MHC403/+ myocytes,
we utilized an indirect measurement of intracellular Ca2+ to understand the underlying
mechanism of contractile and relaxation dysfunction. In an earlier
study, Sen et al. (25), using the Syrian hamster (Bio 14.6 strain) as a
model of the hereditary cardiomyopathy, observed distinct abnormalities
of contractile function in cardiomyopathic cells, i.e., decreases in
amplitude and velocity of contraction but not in diastolic relaxation
velocity. They (25) also noted that mean cytosolic
Ca2+ was significantly higher and
Ca2+ uptake was significantly
increased in cardiomyopathic cells compared with normal control cells,
suggesting that abnormal myocardial Ca2+ homeostasis has a possible
role in contractile dysfunction. This has been noted by others (14, 15)
in hereditary cardiomyopathy. In the present study, we observed delayed
sequestration of Ca2+ into the
sarcoplasmic reticulum during relaxation, although the levels of
diastolic free Ca2+ concentration
were similar between WT and
-MHC403/+ mice. Several other
studies of pressure-overload hypertrophy have identified delayed
relaxation in isolated papillary muscles and isolated myocytes using
human (11) and various other models such as ferret (12), rat (13, 27),
guinea pig (17), and cat (1-3). Furthermore, prior
studies also demonstrated that the mechanism responsible for the
diastolic dysfunction in pressure-overload hypertrophy involves
impaired Ca2+ reuptake due to a
decrease in SERCA (4, 5, 17-19, 21). In addition, transgenic mice
with cardiac-specific overexpressed phospholamban exhibit decreases in
baseline contractile and relaxation function that are associated with
decreases in the amplitude of the
Ca2+ transient and prolongation of
Ca2+ reuptake in isolated myocytes
(16). One possibility for the impaired reuptake of
Ca2+ with
-MHC430/+ mice involved
decreased SERCA levels. However, we found no change in message levels
of SERCA in
-MHC430/+ myocytes
compared with those in WT myocytes. Interestingly, prior studies by
Sweeney et al. (26) and Lankford et al. (20) demonstrated that
replacement of Arg-403 with Gln decreased the rate of transition within
the actin-myosin cross-bridge cycle, depressed myosin ATPase activity,
and displayed abnormal force-velocity relationships. Thus, although we
do not know the exact mechanism for the alteration of
Ca2+ reuptake, it is conceivable
that the disorientation of myofibrils alters cross-bridge kinetics,
which could result in not only contractile but also relaxation dysfunction.
In conclusion,
-MHC403/+
myocytes demonstrated impaired contraction and relaxation. The impaired
function in
-MHC403/+ myocytes
may be due, at least in part, to distinct abnormalities of morphology,
i.e., marked misalignment of myofibrils. Potentially, these myocytes
with abnormal morphology are those that exhibit a more severe phenotype
of the Arg403
Gln
missense mutation. The altered cardiac dysfunction of
-MHC403/+ myocytes is directly
due to defective myocyte function rather than to secondary changes in
global cardiac function and/or loading conditions. Furthermore,
alterations in the rate of contraction and relaxation in the face of
preserved percent contraction, in combination with preserved ejection
fraction (unpublished data), support the concept that the reduced rate
of contraction and relaxation in isolated myocytes is an early finding
that occurs before decreased global systolic function.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported in part by National Heart, Lung, and Blood Institute Grants HL-59139, HL-37404, and HL-33107. The contributions of the first two authors are equal.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: S. F. Vatner, Cardiovascular and Pulmonary Research Inst., Allegheny Univ. of the Health Sciences, 320 East North Ave., Pittsburgh, PA 15212 (E-mail: svatner{at}pgh.auhs.edu).
Received 29 January 1998; accepted in final form 18 January 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bailey, B. A.,
K. Dipla,
S. Li,
and
S. R. Houser.
Cellular basis of contractile derangements of hypertrophied feline ventricular myocytes.
J. Mol. Cell. Cardiol.
29:
1823-1835,
1997[Medline].
2.
Bailey, B. A.,
and
S. R. Houser.
Calcium transients in feline left ventricular myocytes with hypertrophy induced by slow progressive pressure overload.
J. Mol. Cell. Cardiol.
24:
365-375,
1992[Medline].
3.
Bailey, B. A.,
and
S. R. Houser.
Sarcoplasmic reticulum-related changes in cytosolic calcium in pressure-overload-induced feline LV hypertrophy.
Am. J. Physiol.
265 (Heart Circ. Physiol. 34):
H2009-H2016,
1993
4.
Chang, K. C.,
J. H. Schreur,
M. W. Weiner,
and
S. A. Camacho.
Impaired Ca2+ handling is an early manifestation of pressure-overload hypertrophy in rat hearts.
Am. J. Physiol.
271 (Heart Circ. Physiol. 40):
H228-H2234,
1996
5.
De la Bastie, D.,
D. Levitsky,
L. Rappaport,
J. J. Mercadier,
F. Marotte,
C. Wisnewsky,
V. Brovkovich,
K. Schwartz,
and
A. M. Lompre.
Function of the sarcoplasmic reticulum and expression of its Ca2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat.
Circ. Res.
66:
554-564,
1990
6.
Del Monte, F.,
A. J. Kaumann,
P. A. Poole-Wilson,
D. G. Wynne,
J. Pepper,
and
S. E. Harding.
Coexistrance of functioning
1- and
2-adrenoceptors in single myocytes from human ventricle.
Circulation
88:
854-863,
1993
7.
Epstein, N. D.,
G. M. Cohn,
F. Cyran,
and
L. Fananapazir.
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the
-myosin heavy chain gene.A 908Leu
Val mutation and a 403Arg
Gln mutation.
Circulation
86:
345-352,
1992
8.
Fananapazir, L.,
and
N. D. Epstein.
Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical
-myosin heavy chain gene mutations.
Circulation
89:
22-32,
1994
9.
Geisterfer-Lowrance, A. A. T.,
M. Christe,
D. A. Conner,
J. S. Ingwall,
F. J. Schoen,
C. E. Seidman,
and
J. G. Seidman.
A mouse model of familial hypertrophic cardiomyopathy.
Science
272:
731-734,
1996[Abstract].
10.
Geisterfer-Lowrance, A. A. T.,
S. Kass,
G. Tanigawa,
H. P. Vosberg,
W. McKenna,
C. E. Seidman,
and
J. G. Seidman.
A molecular basis for familial hypertrophic cardiomyopathy: A
cardiac myosin heavy chain gene missense mutation.
Cell
62:
999-1006,
1990[Medline].
11.
Gwathmey, J. K.,
and
J. P. Morgan.
Altered calcium handling in experimental pressure-overload hypertrophy in the ferret.
Circ. Res.
57:
836-843,
1985
12.
Gwathmey, J. K.,
S. E. Warren,
G. M. Briggs,
L. Copelas,
M. D. Feldman,
P. J. Phillips,
M. Callahan,
F. J. Schoen,
W. Grossman,
and
J. P. Morgan.
Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole.
J. Clin. Invest.
87:
1023-1031,
1991.
13.
Ito, N.,
J. Bartunek,
K. W. Spitzer,
and
B. H. Lorell.
Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes.
Circulation
95:
2303-2311,
1997
14.
Jasmin, G.,
and
L. Proschek.
Calcium and myocardial cell injury. An appraisal in the cardiomyopathic hamster.
Can. J. Physiol. Pharmacol.
62:
891-898,
1984[Medline].
15.
Jasmin, G.,
and
L. Proschek.
Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line.
Muscle Nerve
5:
20-25,
1982[Medline].
16.
Kadambi, V. J.,
S. Ponniah,
J. M. Harrer,
B. D. Hoit,
G. W. Dorn II,
R. A. Walsh,
and
E. G. Kranias.
Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
J. Clin. Invest.
97:
533-539,
1996[Medline].
17.
Kiss, E.,
N. A. Ball,
E. G. Kranias,
and
R. A. Walsh.
Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca2+-ATPase protein levels.
Circ. Res.
77:
759-764,
1995
18.
Komuro, I.,
M. Kurabayashi,
Y. Shibazaki,
F. Takaku,
and
Y. Yasaki.
Molecular cloning and characterization of a Ca2+ + Mg2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage.
J. Clin. Invest.
83:
1102-1108,
1989.
19.
Lamers, J. M. J.,
and
F. T. Stinis.
Defective calcium pump in the sarcoplasmic reticulum of the hypertrophied rabbit heart.
Life Sci.
24:
2313-2320,
1979[Medline].
20.
Lankford, E. B.,
N. D. Epstein,
L. Fananapazir,
and
H. L. Sweeney.
Abnormal contractile properties of muscle fibers expressing
-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.
J. Clin. Invest.
95:
1409-1414,
1995.
21.
Levitsky, D.,
D. De la Bastie,
K. Schwartz,
and
A.-M. Lompre.
Ca2+-ATPase and function of sarcoplasmic reticulum during cardiac hypertrophy.
Am. J. Physiol. Suppl. (Oct.)
261:
23-26,
1991.
22.
Marian, A. J.,
G. Zhao,
Y. Seta,
R. Roberts,
and
Q. Yu.
Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility.
Circ. Res.
81:
76-85,
1997
23.
Maron, B. J.,
T. Anan,
and
W. Roberts.
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy.
Circulation
63:
882-894,
1981
24.
Schwartz, K.,
L. Carrier,
P. Guicheney,
and
M. Komajda.
Molecular basis of familiar cardioymyopathies.
Circulation
91:
532-540,
1995
25.
Sen, L.,
M. O'Neill,
J. D. Marsh,
and
T. W. Smith.
Myocyte structure, function, and calcium kinetics in the cardiomyopathic hamster heart.
Am. J. Physiol.
259 (Heart Circ. Physiol. 28):
H1533-H1543,
1990
26.
Sweeney, H. L.,
A. J. Straceski,
L. A. Leinwand,
B. A. Tikunov,
and
L. Faust.
Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.
J. Biol. Chem.
269:
1603-1605,
1994
27.
Tsutsui, H.,
Y. Ishibashi,
K. Imanaka-Yoshida,
S. Yamamoto,
T. Yoshida,
M. Sugimachi,
Y. Urabe,
and
A. Takeshita.
Alterations in sarcoplasmic reticulum calcium-storing proteins in pressure-overload cardiac hypertrophy.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H168-H175,
1997
28.
Watkins, H.,
J. G. Seidman,
and
C. E. Seidman.
Familiar hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy.
Hum. Mol. Genet.
4:
1721-1727,
1995[Abstract].
29.
Williford, D. J.,
V. K. Sharma,
M. Korth,
and
S. Shen.
Spatial heterogeneity of intracellular Ca2+ concentration in nonbeating guinea pig ventricular myocytes.
Circ. Res.
66:
234-241,
1990
This article has been cited by other articles:
![]() |
B. M. Palmer, Y. Wang, P. Teekakirikul, J. T. Hinson, D. Fatkin, S. Strouse, P. VanBuren, C. E. Seidman, J. G. Seidman, and D. W. Maughan Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1939 - H1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Palmer, D. E. Fishbaugher, J. P. Schmitt, Y. Wang, N. R. Alpert, C. E. Seidman, J. G. Seidman, P. VanBuren, and D. W. Maughan Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H91 - H99. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Olsson, B. M. Palmer, B. L. Stauffer, L. A. Leinwand, and R. L. Moore Morphological and Functional Alterations in Ventricular Myocytes From Male Transgenic Mice With Hypertrophic Cardiomyopathy Circ. Res., February 6, 2004; 94(2): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Heller, D. E. Mohrman, J. A. Smith, and K. B. Wallace Multitrack system for superfusing isolated cardiac myocytes Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1872 - H1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fatkin and R. M. Graham Molecular Mechanisms of Inherited Cardiomyopathies Physiol Rev, October 1, 2002; 82(4): 945 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Hardt, Y.-J. Geng, O. Montagne, K. Asai, C. Hong, G. P. Yang, S. P. Bishop, S.-J. Kim, D. E. Vatner, C. E. Seidman, et al. Accelerated Cardiomyopathy in Mice With Overexpression of Cardiac Gs{alpha} and a Missense Mutation in the {alpha}-Myosin Heavy Chain Circulation, February 5, 2002; 105(5): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, Y.-K. Kim, G. Takagi, C.-H. Huang, Y.-J. Geng, and S. F. Vatner Enhanced iNOS function in myocytes one day after brief ischemic episode Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H423 - H428. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Nagueh, H. A. Kopelen, D.-S. Lim, W. A. Zoghbi, M. A. Quinones, R. Roberts, and A. J. Marian Tissue Doppler Imaging Consistently Detects Myocardial Contraction and Relaxation Abnormalities, Irrespective of Cardiac Hypertrophy, in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy Circulation, September 19, 2000; 102(12): 1346 - 1350. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |